| Product Code: ETC11387563 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Antibody Discovery Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Antibody Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Antibody Discovery Market - Industry Life Cycle |
3.4 Sweden Antibody Discovery Market - Porter's Five Forces |
3.5 Sweden Antibody Discovery Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Sweden Antibody Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.7 Sweden Antibody Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
4 Sweden Antibody Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases driving demand for antibody therapies |
4.2.2 Technological advancements in antibody discovery techniques leading to more efficient and effective solutions |
4.2.3 Growing investments in research and development in the biopharmaceutical sector in Sweden |
4.3 Market Restraints |
4.3.1 High costs associated with antibody discovery and development processes |
4.3.2 Stringent regulatory requirements and lengthy approval processes for antibody therapies |
5 Sweden Antibody Discovery Market Trends |
6 Sweden Antibody Discovery Market, By Types |
6.1 Sweden Antibody Discovery Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Sweden Antibody Discovery Market Revenues & Volume, By Technology, 2021 - 2031F |
6.1.3 Sweden Antibody Discovery Market Revenues & Volume, By Hybridoma, 2021 - 2031F |
6.1.4 Sweden Antibody Discovery Market Revenues & Volume, By Phage Display, 2021 - 2031F |
6.1.5 Sweden Antibody Discovery Market Revenues & Volume, By Single-Cell Screening, 2021 - 2031F |
6.2 Sweden Antibody Discovery Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Sweden Antibody Discovery Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.2.3 Sweden Antibody Discovery Market Revenues & Volume, By Academic Institutes, 2021 - 2031F |
6.2.4 Sweden Antibody Discovery Market Revenues & Volume, By CROs, 2021 - 2031F |
6.3 Sweden Antibody Discovery Market, By Therapeutic Area |
6.3.1 Overview and Analysis |
6.3.2 Sweden Antibody Discovery Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Sweden Antibody Discovery Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.3.4 Sweden Antibody Discovery Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
7 Sweden Antibody Discovery Market Import-Export Trade Statistics |
7.1 Sweden Antibody Discovery Market Export to Major Countries |
7.2 Sweden Antibody Discovery Market Imports from Major Countries |
8 Sweden Antibody Discovery Market Key Performance Indicators |
8.1 Number of new antibody patents filed in Sweden |
8.2 Research and development expenditure in the biopharmaceutical sector |
8.3 Number of collaborations and partnerships in antibody discovery research in Sweden |
9 Sweden Antibody Discovery Market - Opportunity Assessment |
9.1 Sweden Antibody Discovery Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Sweden Antibody Discovery Market Opportunity Assessment, By End User, 2021 & 2031F |
9.3 Sweden Antibody Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10 Sweden Antibody Discovery Market - Competitive Landscape |
10.1 Sweden Antibody Discovery Market Revenue Share, By Companies, 2024 |
10.2 Sweden Antibody Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here